Ways to Reduce the Risk of Prostate Cancer

In the event the women tend to be afraid of to be the suspect of breast or cervical cancer, consequently, prostate cancer is something actually destructive for a lot of adult males. Without a doubt, almost all males above the 50 are having precisely the same danger of being the patients of this kind of cancer. Not just is it troubling your activities too much, it may also result the death for the chronic situations. Nevertheless, instead of you have to waste more money and energy just for this, it's significantly better for you to prevent it as quickly as you can. Here are various things that you should do to maintain your reproduction system healthy even while decreasing the potential of being the patient of prostate cancer. For this reason, just check them out.

Drinking Pure Water Frequently

Pure water treatment is among the most effective approaches if you prefer to keep away from any high-risk illnesses, like prostate cancer. Because it can merely smooth the urinary system, then you're able to diminish the risk of this type of cancer just a long day before. Certainly, it can also recharge your body to ensure that the risks of other illnesses can also be reduced very easily.

Diet for Prostate Cancer

This kind of diet is especially a program developed for adult males who prefer diminishing the threat of prostate cancer since young age. Of course, there are various kinds of foods that should be avoided such as the red meat. There's a study that correlates the high consumption of red meat and also the chance of prostate cancer. However, it really is much better for you to consume more fruits, vegetables, oatmeal and cereals. The nuts can also be good to be consumed since it could boost the amount of protein on your body. Apart from, since it's containing the antioxidant substance, it's so significantly better to prevent cancer.

Increasing the Zinc Consumption

The prostate gland mostly needs the containing of zinc rather than other organs in your entire body. It's primarily functioned to adjust the steroid hormone metabolism so that decrease the risk of prostate swelling. This substance is particularly contained in a number of types of foods and dishes just like the grains. Well now, it truly is time for you to use the grains or cereals as your primary carbohydrate resource.

Consuming More Vitamin

Aside from the protein or carbohydrate from the grains, there is certainly another matter that you need to consume more; it's relating to the vitamin D and E. Those types of vitamin are called one of the most efficient ways that you simply need to try to reduce the chance of prostate cancer.

Exercise Regularly

Putting on a healthy lifestyle looks not complete without you do such workout regularly. Physical exercise implies that you can just run over the area near your house or head to the gymnastic. This activity is helping you so much in maintaining your reproduction area healthy; consequently, you'll be able to basically diminish the risk of being the patient of prostate cancers.

Although it has been described above that prostate cancer is mainly targeting the adult men over 50, it is also any possibility that it could lash out the younger men. As a result, it is not deniable that the healthy lifestyles mentioned above should be employed as quickly as you can.

I'm a free blogger that interested on prostate cancer. This article will guide you of the things that you should do to avoid the prostate cancer.

View the original article here

Vegetable Fats Reduce Prostate Cancer Death Risk

Editor's Choice
Academic Journal
Main Category: Prostate / Prostate Cancer
Also Included In: Nutrition / Diet;??Cancer / Oncology;??Neurology / Neuroscience
Article Date: 11 Jun 2013 - 0:00 PDT Current ratings for:
Vegetable Fats Reduce Prostate Cancer Death Risk

Prostate cancer patients who replace animal fats and some carbohydrates with vegetable fats have a lower risk of premature death, researchers from the University of California reported in JAMA Internal Medicine.

In the United States alone, nearly 2.5 million men currently live with prostate cancer. Not much is known about how diet may influence prostate cancer progression and death rates, the authors wrote as background information.

Erin L. Richman, Sc.D., and team carried out a study involving 4,577 men from the Health Professional Follow-up Study with non-metastatic prostate cancer between 1986 and 2010. They focused on the patients' dietary fat intake after diagnosis. Every four years, they completed questionnaires which asked how often they ate and drank over 130 different types of foods and drinks.

Over a follow-up period of 8.4 years, 315 men died from prostate cancer and 1,064 died from any cause. Those who replaced 10% of their dietary calorific intake of carbohydrates with vegetable fat had a 29% lower risk of lethal prostate cancer and a 26% lower risk of death from any cause.

The authors wrote:

"In this prospective analysis, vegetable fat intake after diagnosis was associated with a lower risk of lethal prostate cancer and all-cause mortality."

The results of this study go against what many doctors advise their recently diagnosed prostate cancer patients to do, which is "Cut out all fats from your diet". The right advice appears to be to tell the patient to consume more fat, fewer carbohydrates, and to make sure the fats come from plants and not animals.

The authors concluded:

"Overall, our findings support counseling men with prostate cancer to follow a heart-healthy diet in which carbohydrate calories are replaced with unsaturated oils and nuts to reduce the risk of all-cause mortality. ... The potential benefit of vegetable fat consumption for prostate cancer-specific outcomes merits further research."

Dr. Stephen J. Freedland, from Duke University Medical Center, Durham, North Carolina wrote in an invited Commentary:

"Using data from food frequency questionnaires completed every four years during follow-up, they found that men who consumed more vegetable fat had a lower risk of prostate cancer death.

Thus, in the absence of randomized trial data, it is impossible to use these data as 'proof' that vegetable intake lowers prostate cancer risk, and the authors have carefully avoided such statements.

Dr. Freedland says that the only modifiable risk factor associated with prostate cancer death risk is obesity. In other words, if you are diagnosed with prostate cancer, make sure you don't become obese, and if you are, lose weight.

How to avoid becoming or remaining obese remains unclear, although Richman and team's study suggests that switching from animal fats and some carbohydrates to vegetable fats may have some benefit.

Freedland concluded that "Determining whether this benefit is due to reduced consumption of carbohydrates or greater intake of vegetables will require future prospective randomized trials."

Low fat diet with fish oil supplements slow down prostate cancer progression

Scientists from UCLA's Jonsson Comprehensive Cancer Center reported in the American Association for Cancer Research that men who ate a low-fat diet with fish oil supplements had slower progressing prostate cancer compared to those on a traditional Western diet that was high in fat.

The researchers also found that the participants on a low-fat, fish oil supplement diet were able to change the structure of the cell membranes in both healthy and malignant cells in the prostate. They wrote "They had increased levels of omega-3 fatty acids from fish oil and decreased levels of omega-6 fatty acids from corn oil in the cell membranes, which may directly affect the biology of the cells, though further studies are needed."

When blood samples were tested in a test tube, the team found that the growth of prostate cancer cells was much slower among the men on the low-fat, fish oil supplement diet.

Mediterranean diet reduces prostate cancer risk

An article published in UroToday showed that a traditional Cretan Mediterranean diet may help reduce the risk of prostate cancer. A typical diet from Crete, a Greek island in the Mediterranean, is based on plenty of plant foods (vegetables, fruits, wholegrain cereals, legumes and nuts), olive oil as the main source of dietary fat, low red meat consumption, moderate to low consumption of dairy products, moderate to high fish intake, and moderate intake of wine (consumed mainly with meals).

The authors added that the Mediterranean diet has other health benefits and can help protect against cardiovascular and cancer mortality, as well as Parkinson's and Alzheimer's diseases.

Vegan diet plus exercise may halt/reverse prostate cancer progression

Men with early stage prostate cancer who adopted a vegan diet and did plenty of exercise were more likely to stop and even reverse their cancer progression, researchers from the Department of Urology, the University of California, San Francisco, and the Memorial Sloan-Kettering Cancer Center reported in the Journal of Urology (September 2005 issue).

The authors claimed that theirs was the first randomized, controlled trial that demonstrated clearly that lifestyle changes may influence the progression of any type of cancer.

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our prostate / prostate cancer section for the latest news on this subject. "Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality"
Erin L. Richman, ScD; Stacey A. Kenfield, ScD; Jorge E. Chavarro, MD, ScD; Meir J. Stampfer, MD, DrPH; Edward L. Giovannucci, MD, ScD; Walter C. Willett, MD, DrPH; June M. Chan, ScD
JAMA Intern Med. 2013;():1-8. doi:10.1001/jamainternmed.2013.6536

Invited Commentary
"Dietary Fat and Reduced Prostate Cancer Mortality: Does the Type of Fat Matter?Comment on “Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality”
Stephen J. Freedland, MD
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.7744

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Nordqvist, Christian. "Vegetable Fats Reduce Prostate Cancer Death Risk." Medical News Today. MediLexicon, Intl., 11 Jun. 2013. Web.
11 Jun. 2013. APA

Please note: If no author information is provided, the source is cited instead.

'Vegetable Fats Reduce Prostate Cancer Death Risk'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Aspirin May Reduce Risk of Breast Cancer Recurrence and Death

Among women who are at least one year beyond a diagnosis of early-stage breast cancer, regular aspirin use may reduce the risk of breast cancer recurrence and death. These results were published in the Journal of Clinical Oncology.

Nonsteroidal anti-inflammatory drugs (NSAIDS) include drugs such as aspirin and ibuprofen. These drugs are commonly used to reduce inflammation and relieve pain. Studies conducted in the lab suggest that these drugs may have the ability to reduce breast cancer growth.

To explore the relationship between aspirin use and breast cancer outcomes, researchers conducted a study among more than 4,000 participants in the Nurses’ Health Study. The women included in the analysis had been diagnosed with Stage I-Stage III breast cancer between 1976 and 2002, and were observed until 2006.

Because women undergoing cancer treatment may need to avoid aspirin, information about aspirin use was not collected until at least one year after breast cancer diagnosis.

Compared with women who reported no aspirin use, risk of breast cancer death was reduced by 71% among women who used aspirin 2-5 times per week and by 64% among women who used aspirin 6-7 days per week.? Risk of distant recurrence was also reduced among aspirin users.The effect of aspirin on risk of distant recurrence and death did not appear to vary by cancer stage, menopausal status, body mass index, or estrogen receptor status.

These results suggest that among women living at least one year after a breast cancer diagnosis, regular aspirin use may reduce the risk of cancer recurrence and death. However, there are significant limitations of the study and aspirin should not be considered a standard treatment to prevent breast cancer recurrence.? In addition, there are risks associated with regular aspirin use.? Women with a history of breast cancer should talk to their doctors if they have further questions.

Reference: Holmes MD, Chen WY, Li L et al. Aspirin intake and survival after breast cancer. Journal of Clinical Oncology [early online publication]. February 16, 2010.

View the original article here

Higher Copayments Reduce Use of Aromatase Inhibitors for Breast Cancer

Among breast cancer patients treated with an aromatase inhibitor (a type of hormonal therapy), those with high insurance co-payments are more likely to quit aromatase inhibitor treatment or not to take it as directed. These results were published in the Journal of Clinical Oncology.?

Each year roughly 200,000 U.S. women are diagnosed with breast cancer. Many of these breast cancers are hormone receptor-positive, meaning that exposure to estrogen and/or progesterone can cause them to grow.?

Treatment of hormone receptor-positive breast cancer often includes hormonal therapies—such as tamoxifen or an aromatase inhibitor—that suppress or block the action of estrogen. Tamoxifen acts by blocking estrogen receptors, and aromatase inhibitors suppress the production of estrogen in postmenopausal women. Aromatase inhibitors include FemaraR (letrozole) ArimidexR (anastrozole), and AromasinR (exemestane). ?

For breast cancer patients who are prescribed hormonal therapy, it’s important to follow the physician’s instructions in order to achieve the best outcome. Several factors—including cost—may make it difficult to stick with treatment, but little research has been done on how medication cost affects adherence to hormonal therapy. ?

To evaluate whether insurance co-payments affect a woman’s willingness or ability to complete aromatase inhibitor treatment, researchers conducted a study of more than 8,000 women between the ages of 50 and 65 and more than 14,000 women age 65 or older. All the women had insurance coverage for prescription drugs and had been given a prescription for an aromatase inhibitor after surgery for early-stage breast cancer.?

Among women between the ages of 50 and 65, 21% stopped aromatase inhibitor earlier than was recommended, and an additional 11% took less than 80% of the prescribed doses.?Among women age 65 or older, 25% stopped aromatase inhibitor earlier than was recommended, and an additional 9% took less than 80% of the prescribed doses.?In both age groups, stopping treatment early was more common among women who had a higher number of other prescriptions and women whose aromatase inhibitor prescription came from someone other than an oncologist.?Women who had a high prescription co-payment were also more likely to stop AI treatment early. Young women were more likely to stop treatment early if their co-pay was more than $90 for a three-month supply. Older women were more likely to stop treatment early if their co-pay was more than $30 for a three-month supply. ?

This study suggests that higher drug costs lead some breast cancer patients not to complete their full course of hormonal therapy. The researchers conclude “Because noncompliance is associated with worse outcomes, future policy efforts should be directed toward interventions that would help patients with financial difficulties obtain life-saving medications.”?

Reference: Neugut AI, Subar M, Wilde TY et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. Journal of Clinical Oncology. Early online publication May 23, 2011.?

View the original article here

Estrogen Alone May Reduce Breast Cancer Risk in Certain Women

Among women at low risk of breast cancer, postmenopausal hormone therapy with estrogen alone may reduce the risk of breast cancer. These results—which warrant additional research and should not be considered conclusive—came from further review of the Women’s Health Initiative clinical trial of estrogen alone and were presented at the 2010 San Antonio Breast Cancer Symposium (SABCS).

Hormone therapy with estrogen (with or without progestin) effectively manages many menopausal symptoms, but studies over the last several years have raised concerns about the health effects of postmenopausal hormone therapy. In the Women’s Health Initiative (WHI) clinical trial of estrogen plus progestin, hormone use decreased the risks of fracture and colorectal cancer, but increased the risks of heart disease, breast cancer, stroke, and blood clots.[1] More recent reports suggest that combined hormone therapy may also increase lung cancer mortality.[2]

Estrogen alone did not appear to increase the risk of breast or lung cancer but did increase risk of stroke.[3] Because estrogen alone increases the risk of endometrial (uterine) cancer, it is generally reserved for women who have had a hysterectomy.

In the results presented at SABCS, researchers evaluated subgroups of women enrolled in the WHI trial of estrogen alone.[4]

In the subgroups of women at low risk of breast cancer (women without a strong family history of breast cancer and women without a personal history of breast disease), use of estrogen alone was linked with a reduced risk of breast cancer. Among younger women (those under the age of 60), there was a suggestion that the benefits of estrogen alone may outweigh the risks for many women.

These results were discussed at a press conference moderated by Judy Garber, MD, MPH. Dr. Garber described the results as “provocative and preliminary.” Further research is required before firm conclusions can be drawn about the relationship between estrogen alone and risk of breast cancer.

?References:

[1] Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288:321-33

[2] Chlebowski RT, Schwartz AG, Wakelee H et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women’s Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet. 2009;374:1243-1251.

[3] Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004; 291:1701-1712.

[4] Ragaz J, Bajdik C, Wilson KS et al. Dual estrogen effects on breast cancer: endogenous estrogen stimulates while exogenous estrogen protects. Presented at the 33rd annual San Antonio Breast Cancer Symposium, December 8-12, 2010.

View the original article here